X

Vous n'êtes pas connecté

  - STOCKHEAD.COM.AU - A La Une - 01/Jul 01:40

Optiscan begins breast cancer study in Melbourne

Optiscan’s latest study is now underway, using its InVue and InForm devices to help surgeons assess breast cancer margins in ...

Articles similaires

Sorry! Image not available at this time

Melbourne breast cancer trial to test Optiscan imaging device

smh.com.au - 01/Jul 03:46

Optiscan Imaging is recruiting patients into a Melbourne trial of its innovative precision surgery and pathology devices to improve breast cancer...

Scorpion venom offers new hope for breast cancer patients: Study

times of india - 24/Jun 12:18

Brazilian scientists have identified a molecule, BamazScplp1, in Amazonian scorpion venom that effectively kills breast cancer cells in early tests....

Sorry! Image not available at this time

Geisinger expands 3D mammography

wn.com - 02/Jul 12:54

The Daily Item DANVILLE — Geisinger now offers 3D mammography systemwide, providing patients across its service area with access to the latest, best...

Sorry! Image not available at this time

Geisinger expands 3D mammography

wn.com - 02/Jul 12:54

The Daily Item DANVILLE — Geisinger now offers 3D mammography systemwide, providing patients across its service area with access to the latest, best...

Sorry! Image not available at this time

This is the terrifying truth about alternative cancer therapies - and what happened when I ...

wn.com - 29/Jun 11:51

The message, from a stranger on Instagram, absolutely broke me. 'Dear Liz,' it began, 'I need to tell you about a friend with advanced breast cancer....

Sorry! Image not available at this time

This is the terrifying truth about alternative cancer therapies - and what happened when I ...

wn.com - 29/Jun 11:51

The message, from a stranger on Instagram, absolutely broke me. 'Dear Liz,' it began, 'I need to tell you about a friend with advanced breast cancer....

Sorry! Image not available at this time

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

drugs.com - 20/Jun 15:06

FRIDAY, June 20, 2025 -- Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy,...

Sorry! Image not available at this time

Nearly Half With Early-Stage Breast Cancer Extend Endocrine Therapy Beyond Five Years

drugs.com - 20/Jun 15:06

FRIDAY, June 20, 2025 -- Nearly 40 percent of women with stage I breast cancer and two-thirds with stage II decide to extend endocrine therapy,...

Targeting mitochondrial dynamics to combat breast cancer metastasis

news.medical.net - 28/Jun 01:31

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to its aggressive nature and...

Les derniers communiqués

  • Aucun élément